Entiformin Tablet 500mg (Metformin Hydrochloride)
Metformin Hydrochloride 500mg
Tablet · Prescription medication
Korea Sintax Pharmaceutical Co., Ltd.
MFDS item code 201906905 · Approved 2019.09.30
This product's status changed to Expired on 2024.09.30. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of type 2 diabetes mellitus
This medication is used for the treatment of patients with type 2 diabetes whose blood sugar control is insufficient with diet and exercise alone, especially in overweight individuals. In adults, it can be used alone or in combination with other oral hypoglycemic agents or insulin. In addition, it can be used alone or with insulin in children over the age of 10 and adolescents in the growth phase, helping with blood sugar control across various age groups. This medication effectively lowers blood sugar and improves diabetes management.
The dose should be determined individually based on drug efficacy and tolerability and should not exceed the recommended maximum daily dose. To reduce gastrointestinal adverse reactions and identify the minimum dose required for adequate glycemic control, this medicine must be started at a low dose. Take 500mg per dose 2~3 times daily with meals. Increase the dose gradually by 500mg each week. When taking up to 2000mg, the dose is usually divided into 2 doses daily, in the morning and evening. For doses exceeding 2000mg, administer in 3 divided doses with meals; the maximum daily dose is 2550mg. When initiating treatment and adjusting the dose, measure fasting blood glucose to assess the therapeutic response to this medicine and identify the minimum effective dose. Measure blood glycosylated hemoglobin levels at approximately 3-month intervals. The goal of treatment with this medicine, whether used as monotherapy or in combination with a sulfonylurea or insulin, is to reduce fasting blood glucose and blood glycosylated hemoglobin levels to normal or near-normal levels using the minimum effective dose. In general, when a patient whose blood glucose was controlled by diet alone temporarily loses glycemic control, a short course of this medicine may be sufficient to achieve an adequate effect. This medicine may be used in patients with moderate stage 3a renal impairment (creatinine clearance [CrCl] 45≤~<60ml/min or glomerular filtration rate (GFR) 45≤~<60mL/min/1.73㎡) who have no other condition that may increase the risk of lactic acidosis, with the following dose adjustments. - The starting dose is 500mg or 850mg once daily. The maximum daily dose is 1000mg, administered in 2 divided doses. Renal function should be closely monitored every 3-6 months. If creatinine clearance or glomerular filtration rate falls below 45ml/min or 45ml/min/1.73㎡, respectively, this medicine must be discontinued immediately.
Children aged 10 years and older or adolescents who are still growing: The usual starting dose is 500 milligrams once daily, administered during or after a meal. Measure blood glucose levels after one week and adjust the dose. Gastrointestinal adverse effects may improve with gradual dose increases. The maximum daily dose is 2000mg. Divide this dose into 2~3 doses.
This medication carries a risk of lactic acidosis and hypoglycemia, so caution is needed. It should not be administered to patients with moderate to severe renal impairment or in acute situations that may affect renal function, such as dehydration, serious infections, and acute myocardial infarction. Patients with acute or unstable heart failure or those preparing for tests using iodine contrast agents should also avoid this medication. Patients with a history of hypersensitivity to this medication or biguanides, type 1 diabetes, lactic acidosis, or diabetic ketoacidosis should not use it. Treatment should be temporarily stopped for patients with severe infections, severe traumatic systemic disorders, or those awaiting surgery, until their condition improves. Caution is also required for patients with liver dysfunction, lung function impairment, or excessive alcohol consumption. The medication must be used carefully in patients with irregular meals, insufficient food intake, vigorous exercise, or those taking interacting medications, as they may have an increased risk of lactic acidosis and hypoglycemia. Side effects such as gastrointestinal disturbances, metallic taste, skin rash, blood disorders, liver function abnormalities, and hypoglycemia may occur during treatment, and if symptoms manifest, immediate consultation with healthcare professionals is required. Renal function should be regularly monitored, and if it worsens, medication should be discontinued, particularly for elderly patients or those with declining renal function. Alcohol can affect lactate metabolism with this medication, so excessive consumption should be avoided. During pregnancy, the medication should not be given considering potential effects on the fetus, particularly in cases of placental insufficiency or risk of preeclampsia; consultations with healthcare professionals before planning or during pregnancy are advised. During breastfeeding, since this medication is excreted into breast milk, discussions with healthcare professionals should occur regarding stopping breastfeeding or discontinuing treatment. Special attention is necessary for children and elderly patients, particularly in adjusting doses based on renal function. This medication may affect blood sugar control when used in combination with other hypoglycemic agents, so close monitoring of the combination medication and the patient's condition is required. In case of overdose, blood dialysis may be required, so immediate visits to a healthcare facility should be made. This medication does not cause weight gain, which is advantageous for weight management, and long-term use helps achieve stable blood sugar control and reduce the risk of diabetes complications. Keep this medication out of the reach of children and do not transfer it to other containers.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent exposure to air or moisture. It is best to maintain storage temperatures between 1 degree and 30 degrees Celsius.
White round film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Metformin Hydrochloride 500mg
Tablet · Prescription medication
Korea Sintax Pharmaceutical Co., Ltd.

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Celltrion Pharmaceuticals)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Daewoong Pharmaceutical)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Ildong Pharmaceutical Co., Ltd.)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Ilseong IS Co., Ltd.)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Kyungdong Pharmaceutical Co., Ltd.)

Metformin Hydrochloride 250mg
Tablet · Prescription medication
(Daewoong Pharmaceutical)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Youngpoong Pharmaceutical Co., Ltd.)
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.